beta

ABUS

Arbutus Biopharma Corp.

Abus

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company is headquartered in Burnaby, Canada.

Market Cap: 136 Million

Primary Exchange: NASDAQ

Website: http://www.arbutusbio.com

Shares Outstanding: 56.9 Million

Float: 34 Million

Dividend: (%)

Beta: 1.70677464924199

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Animal testing

Longest drawdown: 1464 trading days

From: 2014-03-11 To: 2019-12-12

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud